Table 1.
Characteristics of the included studies published from 2000 to 2016 in mainland China.
Vaccine Coverage Rate a |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
First Author | Study Year | Age (y or m) | Location in China | Source | Number of strains | Serotype method | PCV10 | PCV13 | PCV23 | |
South | ||||||||||
Yang F20 | 1996–1999 | All age | Shanghai | Non-invasive | 111 | Quellung | 50.5% | 71.2% | 70.3% | |
Yang F21 | 1997–1998 | ≤5 y | Shanghai | Non-invasive | 222 | Quellung | 56.8% | 73.9% | 60.8% | |
Li ZF22 | 1999–2001 | 2–14 y | Guangzhou | Non-invasive | 84 | Quellung | 32.1% | 46.4% | 39.3% | |
Zhao GM23 | 2000-2001 | ≤3 y | Shanghai | Non-invasive+invasive | 112 | Quellung | 72.3% | 81.3% | 72.3% | |
Wang CQ24 | 2000–2001 | <18 y | Shanghai | Non-invasive | 96 | Quellung | 61.5% | 71.9% | 62.5% | |
Wang CQ25 | 2000-2002 | 1m-15 y | Shanghai | Non-invasive | 111 | Quellung | 64.9% | 74.8% | 64.9% | |
Luo XM26 | 2003 | All age | Zhongshan | Non-invasive | 266 | Quellung | 37.6% | 53.0% | 48.1% | |
Sun ZY27 | 2003-2004 | <5 | Wuhan | Non-invasive | 133 | Quellung | 5.3% | 6.0% | 6.0% | |
Zhang J28 | 2004 | unknown | Wuhan | Non-invasive | 152 | Quellung | 4.6% | 6.6% | 7.2% | |
Zhang J29 | 2004 | <18 y | Wuhan | Non-invasive | 114 | Quellung | 6.1% | 7.0% | 7.0% | |
Liu YK30 | 2004-2005 | All age | Wuhan | Non-invasive | 304 | Quellung | 4.6% | 6.6% | 7.2% | |
Yang F31 | 2004–2005 | >18 y;<12 y | Shanghai | Non-invasive | 103 | Quellung, PCR | 71.8% | 84.5% | 86.4% | |
Ren HY32 | 2004–2006 | <18 y | Chengdu | unknown | 123 | Quellung | 52.0% | 60.2% | 68.3% | |
Zhang XH33 | 2004–2009 | ≥18 y | Hunan | Non-invasive+invasive | 822 | Quellung | 5.1% | 20.6% | 20.6% | |
Pan W34 | 2005–2012 | <18 y | Nanjing | invasive strain | 155 | Quellung | 61.3% | 80.6% | 85.8% | |
Yang T35 | 2005–2013 | All age | Guangdong | Non-invasive+invasive | 383 | Quellung | 16.4% | 21.9% | 21.9% | |
Zhao RZ36 | 2006–2007 | ≤5 y | Shenzhen | Non-invasive+invasive | 90 | Quellung | 95.6% | 98.9% | 100.0% | |
Deng QL37 | 2006-2007 | 1m一6 y | Guangzhou | Non-invasive | 79 | Quellung | 94.9% | 94.9% | 97.5% | |
Dong YS38 | 2006–2008 | All age | Chongqing | Non-invasive+invasive | 143 | Quellung | 8.4% | 10.5% | 15.4% | |
Dong YS39 | 2006–2008 | unknown | Chongqing | Non-invasive+invasive | 133 | Quellung | 4.5% | 4.5% | 4.5% | |
Zhang H40 | 2007–2008 | ≤5 y | Shanghai | Non-invasive | 338 | Quellung | 57.7% | 81.1% | 80.5% | |
Xu F41 | 2007–2010 | <18 y | Nanjing | invasive | 48 | Quellung | 70.8% | 93.8% | 95.8% | |
Miao DQ42 | 2007–2011 | <18 y | Nanjing | Non-invasive+invasive | 323 | PCR | 44.0% | 73.7% | 62.8% | |
Hu JY43 | 2009 | 12–18 m | Shanghai | Non-invasive | 102 | Quellung | 63.7% | 77.5% | 71.6% | |
Zhao DF44 | 2009 | 12–18 m | Wuhan | Non-invasive | 75 | Quellung | 38.7% | 54.7% | 46.7% | |
Zhang C45 | 2009–2010 | All age | Sichuan | Non-invasive+invasive | 166 | Quellung | 10.2% | 12.0% | 16.9% | |
Li JP46 | 2009–2010 | <18 y | Zhejiang | Non-invasive | 106 | Quellung | 59.4% | 95.3% | 92.5% | |
Ying QH47 | 2009–2010 | All age | Shaoxing | Non-invasive+invasive | 103 | Quellung | 62.1% | 62.1% | 62.1% | |
Zhang B48 | 2009-2010 | All age | Chongqing | Non-invasive+invasive | 91 | Quellung, PCR | 61.5% | 75.8% | 81.3% | |
Chen DL49 | 2009-2011 | All age | Maanshan | Non-invasive+invasive | 80 | Quellung | 55.0% | 83.8% | 82.5% | |
Ma X50 | 2009-2012 | <14 y | Shenzhen | invasive | 87 | Quellung | 72.4% | 81.6% | 81.6% | |
Lin XF51 | 2009-2013 | ≥18 y | Wenzhou | invasive | 52 | Quellung | 59.6% | 90.4% | 86.5% | |
Zhou K52 | 2009-2013 | <12 y | Nanjing | invasive | 51 | Quellung | 76.5% | 96.1% | 98.0% | |
Jing CM53 | 2009-2014 | <18 y | Chongqing | Non-invasive+invasive | 600 | Quellung | 53.0% | 62.8% | 62.8% | |
Kang LH54 | 2010-2013 | ≤11 y | Chongqing | Non-invasive+invasive | 83 | Quellung, PCR | 51.8% | 79.5% | 73.5% | |
Lu C55 | 2010-2013 | ≤14 y | Shenzhen | invasive | 76 | Quellung | 72.4% | 94.7% | 97.4% | |
Liu MJ56 | 2010-2013 | ≤11 y | Chongqing | Non-invasive+invasive | 46 | PCR | 52.2% | 84.8% | 78.3% | |
Song XQ57 | 2010-2014 | 0-6 y | Taizhou | Non-invasive | 322 | Quellung | 82.9% | 95.7% | 95.7% | |
Li M58 | 2011-2012 | ≤5 y | Humen | Non-invasive | 229 | Quellung | 95.2% | 97.4% | 97.8% | |
Huang SY59 | 2011-2013 | All age | Guangzhou | Non-invasive+invasive | 94 | Quellung | 50.0% | 67.0% | 67.0% | |
Ding YF60 | 2011-2013 | < 18 y | Suzhou | Non-invasive | 79 | PCR | 55.7% | 93.7% | 93.7% | |
Jiang QH61 | 2011-2013 | >18 y | Shanghai | Non-invasive+invasive | 37 | Quellung, PCR | 37.8% | 48.6% | 51.4% | |
Wang JR62 | 2011-2014 | 0-107m | Wenling | unknown | 284 | Quellung | 60.6% | 85.9% | 80.6% | |
Wang LM63 | 2011-2015 | 0-6 y | Jinhua | Non-invasive | 302 | Quellung | 83.8% | 97.7% | 97.7% | |
Li ST64 | 2012 | 1-10 y | Nanjing | Non-invasive | 584 | Quellung | 64.7% | 92.3% | 96.4% | |
Fen P65 | 2012 | 0-14 y | Shanghai | Non-invasive | 328 | Quellung, PCR | 58.2% | 84.1% | 77.4% | |
Yuan YT66 | 2012-2013 | <7 y;>50 y | Xiamen | Non-invasive+invasive | 265 | Quellung | 62.6% | 77.4% | 67.5% | |
Geng Q67 | 2012-2013 | ≤5 y | Suzhou | Non-invasive | 175 | PCR | 66.3% | 84.6% | 84.6% | |
Fen P68 | 2013 | ≤14 y | Shanghai | Non-invasive+invasive | 284 | Quellung, PCR | 58.1% | 81.0% | 79.9% | |
Peng YJ69 | 2015 | ≤12 y | Chongqing | Non-invasive | 267 | Quellung | 49.1% | 72.7% | 66.7% | |
North | ||||||||||
Yu SJ70 | 1997 | ≤5 y | Beijing | Non-invasive | 190 | Quellung | 31.6% | 44.7% | 31.6% | |
MCGEE L 71 | 1997-1998 | ≤5 y | Beijing | Non-invasive | 376 | Quellung | 47.1% | 74.7% | 55.1% | |
Li J72 | 1999 | ≤5 y | Beijing | Non-invasive | 97 | Quellung | 8.2% | 10.3% | 11.3% | |
Yao KH73 | 2000-2002 | <5 y | Beijing | Non-invasive | 63 | Quellung | 4.8% | 4.8% | 6.3% | |
Yao KH74 | 2000-2004 | ≤5 y | Beijing | Non-invasive | 129 | Quellung | 7.0% | 7.0% | 7.8% | |
Yu S75 | 2000-2005 | ≤5 y | Beijing | Non-invasive | 519 | Quellung | 8.3% | 8.5% | 11.6% | |
Tong YJ76 | 2004 | ≤5 y | Beijing | Non-invasive | 137 | Quellung | 10.2% | 10.2% | 14.6% | |
Wu JX77 | 2008-2010 | ≤6 y | Linyi | Non-invasive | 124 | Quellung | 29.8% | 48.4% | 71.8% | |
Liu CF78 | 2009-2011 | 3m-5 y | Shenyang | invasive | 61 | Quellung | 52.5% | 93.4% | 100.0% | |
Zhou L79 | 2010 | ≤5 y | Beijing | Non-invasive | 140 | Quellung | 37.1% | 44.3% | 37.1% | |
Wang TW80 | 2010-2013 | ≤5 y | Dalian | Non-invasive | 131 | PCR | 60.3% | 60.3% | 60.3% | |
Cao XH81 | 2012 | <18 y | Luohe | Non-invasive+invasive | 134 | Quellung | 48.5% | 48.5% | 59.0% | |
Li J82 | 2012-2014 | <18 y | Beijing | Non-invasive+invasive | 103 | Quellung | 59.2% | 86.4% | 80.6% | |
Liu ZW83 | 2013-2014 | ≤3 y | Taian | Non-invasive+invasive | 320 | Quellung | 75.0% | 82.8% | 75.0% | |
Dong F84 | 2013-2014 | <18 y | Beijing | Non-invasive+invasive | 258 | Quellung | 43.0% | 65.5% | 64.0% | |
Yao KH85 | 2013-2014 | ≤14 y | Beijing | Non-invasive+invasive | 187 | Quellung | 25.7% | 55.1% | 46.0% | |
Yu SJ86 | 2013-2014 | ≤16 | Beijing | Non-invasive | 100 | Quellung | 39.0% | 51.0% | 44.0% | |
Zhou MJ87 | 2013-2015 | All age | Baoding | Non-invasive+invasive | 210 | PCR | 35.2% | 62.9% | 51.9% | |
Wang Q88 | 2013-2016 | 3m一7.5 y | Beijing | invasive | 30 | Quellung | 56.7% | 96.7% | 93.3% | |
Wang JF89 | 2014 | <18 y | Zhengzhou | Non-invasive+invasive | 134 | Quellung | 48.5% | 48.5% | 59.0% | |
Wang YT90 | 2014 | ≤8 y | Hebei | invasive | 43 | PCR | 48.8% | 65.1% | 67.4% | |
Zhang M91 | 2014-2015 | <18 y | Jinan | Non-invasive | 42 | Quellung | 9.5% | 9.5% | 23.8% | |
Multicenter | ||||||||||
Yao KH92 | 2000-2002 | <5 y | Multicenter | Non-invasive | 625 | Quellung | 6.6% | 6.6% | 6.6% | |
Li MC93 | 2004-2009 | unknown | Multicenter | unknown | 144 | Quellung | 8.3% | 9.0% | 10.4% | |
Li MC94 | 2004-2011 | unknown | Multicenter | Non-invasive+invasive | 241 | Quellung | 58.9% | 76.8% | 74.3% | |
Liu YD95 | 2005-2006 | ≤4 y | Multicenter | Non-invasive+invasive | 451 | Quellung | 63.6% | 75.4% | 75.4% | |
Xiao SK96 | 2005-2008 | All age | Multicenter | Non-invasive+invasive | 580 | Quellung | 31.7% | 52.6% | 52.6% | |
Liu CL97 | 2005-2008 | All age | Multicenter | invasive | 148 | Quellung | 36.5% | 67.6% | 66.2% | |
Zhao CJ98 | 2005-2011 | All age | Multicenter | Non-invasive+invasive | 240 | Quellung | 34.6% | 63.8% | 63.8% | |
Yao KH99 | 2006-2007 | ≤5 y | Multicenter | Non-invasive+invasive | 279 | Quellung | 81.4% | 92.8% | 93.9% | |
Yao KH100 | 2006-2008 | ≤5 y | Multicenter | Non-invasive+invasive | 338 | Quellung | 74.0% | 87.9% | 87.9% | |
Ma X101 | 2006-2008 | <14 y | Multicenter | invasive | 171 | Quellung | 63.2% | 80.7% | 80.7% | |
Zhang YJ102 | 2007-2011 | All age | Multicenter | Non-invasive+invasive | 39 | Quellung | 64.1% | 87.2% | 89.7% | |
Chen C103 | 2008-2010 | unknown | Multicenter | Non-invasive+invasive | 277 | Quellung | 45.5% | 51.6% | 64.6% | |
Wang Q104 | 2010-2011 | All age | Multicenter | Non-invasive+invasive | 471 | Quellung | 39.1% | 67.5% | 62.6% |
Notes:
Vaccine Coverage Rate was calculated as the percentage of isolates from each study that belonged to the serogroups/serotypes included in the PCVs.